KEROS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.86 USD | +6.77% |
|
-0.72% | +45.52% |
| 19/03 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
| 15/03 | Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 61.71 | 70.48 | 70.48 |
| Spread/Res. | -6.24% | -17.91% | -17.91% |
| Spread/Supp. | +6.77% | +34.15% | +34.50% |
| Support | 54.19 | 43.13 | 43.02 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- KROS Stock
- Charts Keros Therapeutics, Inc.
